Health-related quality of life after hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer: Results of the phase III OVHIPEC study

被引：0
|
作者：
Koole, S. [1 ]
van Driel, W. [1 ]
Kieffer, J. [2 ]
Sikorska, K. [3 ]
van Leeuwen, J. Schagen [4 ]
Schreuder, H. [5 ]
Hermans, R. [6 ]
de Hingh, I. [7 ]
van der Velden, J. [8 ]
Arts, H. [9 ]
Massuger, L. [10 ]
Aalbers, A. [11 ]
Verwaal, V. [12 ]
Van de Vijver, K. [13 ]
Aaronson, N. [2 ]
Sonke, G. [14 ]
机构：
[1] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Dept Gynaecol, Amsterdam, Netherlands
[2] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[3] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Dept Stat, Amsterdam, Netherlands
[4] Sint Antonius Hosp Nieuwegein, Dept Obstet & Gynaecol, Nieuwegein, Netherlands
[5] Univ Med Ctr Utrecht, Dept Gynaecol Oncol, Utrecht, Netherlands
[6] Catharina Hosp, Dept Obstet & Gynaecol, Eindhoven, Netherlands
[7] Catharina Hosp, Dept Surg, Eindhoven, Netherlands
[8] Amsterdam Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands
[9] Univ Med Ctr Groningen, Dept Gynaecol Oncol, Groningen, Netherlands
[10] Radboud Univ Nijmegen, Dept Gynaecol Oncol, Med Ctr, Nijmegen, Netherlands
[11] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
[12] Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark
[13] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[14] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA43
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EORTC phase III on PCV chemotherapy in newly diagnosed anaplastic oligodendrogliomas: Health-related quality of life results
    Taphoorn, M. J. B.
    van den Bent, M. J.
    Mauer, M.
    Coens, C.
    Delattre, J. -Y.
    Brandes, A. A.
    van der Rijt, C. C. D.
    Bernsen, H. J. J. A.
    Frenay, M.
    Tijssen, C. C.
    Lacombe, D.
    Allgeier, A.
    Bottomley, A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [32] Survival and adverse treatment effects of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced stage ovarian cancer
    Potkonjak, Ana-Meyra
    Vranes, Hrvojka Soljacic
    Vukovic, Ante
    Tuckar, Neven
    Butorac, Drazan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A397 - A398
  • [33] Optimally Debulked Stage III Ovarian Cancer Intraperitoneal or Intravenous Chemotherapy?
    Friedlander, Michael
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S20 - S23
  • [34] Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer - Our Experience
    Jaka, R. C.
    Zaveri, S.
    Somashekhar, S. P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S531 - S531
  • [35] Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: A Gynecologic Oncology Group study
    Wenzel, Lari B.
    Huang, Helen Q.
    Armstrong, Deborah K.
    Walker, Joan L.
    Cella, David
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) : 437 - 443
  • [36] Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01)
    Kim, Ji Hyun
    Chun, Sung-Youn
    Lee, Dong-eun
    Woo, Yo Han
    Chang, Suk-Joon
    Park, Sang-Yoon
    Chang, Yoon Jung
    Lim, Myong Cheol
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 19 - 24
  • [37] A phase II randomized study: Outcomes after cytoreductive surgery (CRS) with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by adjuvant chemotherapy as initial treatment of advanced stage (stage III/IV) ovarian, fallopian tube, and primary peritoneal cancer.
    Diaz-Montes, Teresa
    Sittig, Michelle
    Ryu, Hyung
    Gushchin, Vadim
    Sardi, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Consolidation After Complete Neoadjuvant Treatment in Advanced Epithelial Ovarian Cancer: A Pilot Study
    Medina-Franco, H.
    Armengol-Alonso, A.
    Cortes-Gonzalez, R.
    Pastor-Sifuentes, F.
    Colonna, L.
    Magana-Perez, K.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S87 - S87
  • [39] Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
    van der Meulen, M.
    Bakunina, K.
    Nijland, M.
    Minnema, M. C.
    Cull, G.
    Stevens, W. B. C.
    Baars, J. W.
    Mason, K. D.
    Beeker, A.
    Beijert, M.
    Taphoorn, M. J. B.
    van den Bent, M. J.
    Issa, S.
    Doorduijn, J. K.
    Bromberg, J. E. C.
    Dirven, L.
    ANNALS OF ONCOLOGY, 2020, 31 (08) : 1046 - 1055
  • [40] A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve
    Wilson, Michelle K.
    Friedlander, Michael L.
    Joly, Florence
    Oza, Amit M.
    ONCOLOGIST, 2018, 23 (02): : 203 - 213
12345